Showing results (81-90 of 93) with videos related to
Sort By:
Pageof 10
Scientific Reports|January 25, 2020
The optimal sequence of bronchial brushing and washing for diagnosing peripheral lung cancer using non-guided flexible bronchoscopyJun Hyeok Lim, Min Jeong Kim, Sang-Hoon Jeon, et al.Translational Lung Cancer Research|April 23, 2021
Low-level expression of necroptosis factors indicates a poor prognosis of the squamous cell carcinoma subtype of non-small-cell lung cancerJun Hyeok Lim, Sekyung Oh, Lucia Kim, et al.Thoracic Cancer|March 13, 2026
Blood Based Biomarkers for Predicting Treatment Response to Immune Checkpoint Inhibitors After EGFR-TKI Resistance in Non-Small Cell Lung CancerMin Seok Park, Jun Hyeok Lim, Nuri Park, et al.Journal of Pathology and Translational Medicine|March 1, 2019
Provisional Guideline Recommendation for EGFR Gene Mutation Testing in Liquid Samples of Lung Cancer Patients: A Proposal by the Korean Cardiopulmonary Pathology Study GroupDong Hoon Shin, Hyo Sup Shim, Tae Jung Kim, et al.The Journal of Pathology. Clinical Research|October 2, 2024
Deep learning-based analysis of EGFR mutation prevalence in lung adenocarcinoma H&E whole slide imagesJun Hyeong Park, June Hyuck Lim, Seonhwa Kim, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 22, 2025
Avidity-Based Capture of PD-L1-Expressing Exosomes via Dendrimer-Peptide Conjugates: A Nanoengineered Platform for Enhanced Prediction of Immunotherapy ResponseJiah Lee, Dongjun Shin, Chae Yeon Son, et al.Oncotarget|September 17, 2017
Biomarker analysis of the phase 3 TORCH trial for first line erlotinib versus chemotherapy in advanced non-small cell lung cancer patientsLucia Kim, Mauro Saieg, Massimo Di Maio, et al.Oncotarget|March 31, 2016
A window of opportunity study of potential tumor and soluble biomarkers of response to preoperative erlotinib in early stage non-small cell lung cancerAdrian G Sacher, Lisa W Le, Humberto Lara-Guerra, et al.Korean Journal of Pathology|May 14, 2013
No detection of simian virus 40 in malignant mesothelioma in KoreaMinseob Eom, Jamshid Abdul-Ghafar, Sun-Mi Park, et al.Journal of Pathology and Translational Medicine|July 17, 2018
WITHDRAWN:A Clinicopathologic Study of 220 Cases of Pulmonary Sclerosing Pneumocytoma in Korea: A Nationwide SurveyMyunghee Kang, Seung Yeon Ha, Joung Ho Han, et al.Pageof 10